<> Procter & Gamble Health Share Price Today: Live Procter & Gamble Health Share Price NSE/BSE | 5paisa
PGHL

Procter & Gamble Health Share PriceProcter & Gamble Health

₹4070.00
19.85 (0.49%)
  • Advice
  • Hold
As on 30 January, 2023 | 04:38 BSE: 500126 NSE: PGHL

Procter & Gamble Health Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Procter & Gamble Health

Start SIP

Procter & Gamble Health Share Price

  • Over 1 Month -1.06%
  • Over 3 Month 1.1%
  • Over 6 Month -6.49%
  • Over 1 Year -19.47%

Procter & Gamble Health Key Statistics

P/E Ratio 33.6
PEG Ratio 2.1
Market Cap Cr 6,756
Price to Book Ratio 11
EPS 116.2
Dividend 1.3
Relative Strength Index 45.09
Money Flow Index 49.63
MACD Signal -12.7
Average True Range 78.24

Procter & Gamble Health Investment Rating

  • Master Rating:
  • Procter & Gamble Health has an operating revenue of Rs. 1,139.16 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 23% is great, ROE of 31% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Health Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 298296268
Operating Expenses Qtr Cr 207236199
Operating Profit Qtr Cr 915969
Depreciation Qtr Cr 776
Interest Qtr Cr 000
Tax Qtr Cr 231314
Net Profit Qtr Cr 644151

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹4070.
19.85 (0.49%)
  • Bullish Moving Average
  • ___
  • 7
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • 4068.41
  • 50 Day
  • 4096.89
  • 100 Day
  • 4144.62
  • 200 Day
  • 4292.02
  • 20 Day
  • 4048.74
  • 50 Day
  • 4101.89
  • 100 Day
  • 4132.28
  • 200 Day
  • 4211.63

Procter & Gamble Health Resistance and Support

PIVOT
₹4058.05
Resistance
First Resistance 4076.1
Second Resistance 4102.05
Third Resistance 4120.11
RSI 45.09
MFI 49.63
MACD Single Line -12.7
MACD -10.36
Support
First Resistance 4032.1
Second Resistance 4014.05
Third Resistance 3988.1

Procter & Gamble Health Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,557 276,792 60.74
Week 4,434 243,618 54.94
1 Month 9,001 526,131 58.45
6 Month 8,853 604,834 68.32

Procter & Gamble Health Result Highlights

Procter & Gamble Health Synopsis

NSE-Medical-Generic Drugs

P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1114.41 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2022. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
Market Cap 6,711
Sales 1,139
Shares in Float 0.80
No of funds 121
Yield 1.3
Book Value 10.89
U/D Vol ratio 0.6
LTDebt / Equity
Alpha -0.08
Beta 0.44

Procter & Gamble Health

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 51.82%51.82%51.82%
Mutual Funds 7.28%6.9%6.61%
Insurance Companies 5.11%5.66%1.46%
Foreign Portfolio Investors 6.33%6.05%6.47%
Financial Institutions/ Banks
Individual Investors 24.32%24.46%25.09%
Others 5.14%5.11%8.55%

Procter & Gamble Health Management

Name Designation
Mr. Suresh Talwar Chairman & Ind.Director
Mr. Milind Thatte Managing Director
Mr. Amit Gupta Executive Director & CFO
Mr. Aalok Agrawal Non Executive Director
Dr. Elizabeth Desmond Non Executive Director
Mrs. Rani Jadhav Independent Director
Mr. S Madhavan Independent Director

Procter & Gamble Health Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Procter & Gamble Health Corporate Action

Date Purpose Remarks
2023-02-05 Quarterly Results & Interim Dividend
2022-11-11 Quarterly Results (Revised) per share(150%)Dividend
2022-08-29 Audited Results & Final Dividend
2022-05-05 Quarterly Results & Interim Dividend
2022-02-09 Quarterly Results
Date Purpose Remarks
2023-02-13 INTERIM Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23701
HDFC Small Cap Fund Growth 14649
UTI MNC Fund Regular Plan Growth 2453
Tata Flexi Cap Fund Regular Growth 2208
Sundaram Small Cap Fund - Regular Plan - Growth Option 2021

Procter & Gamble Health FAQs

What is Share Price of Procter & Gamble Health ?

Procter & Gamble Health share price is ₹4070 As on 30 January, 2023 | 04:24

What is the Market Cap of Procter & Gamble Health ?

The Market Cap of Procter & Gamble Health is ₹6756 Cr As on 30 January, 2023 | 04:24

What is the P/E ratio of Procter & Gamble Health ?

The P/E ratio of Procter & Gamble Health is 33.6 As on 30 January, 2023 | 04:24

What is the PB ratio of Procter & Gamble Health ?

The PB ratio of Procter & Gamble Health is 11 As on 30 January, 2023 | 04:24

Q2FY23